• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Problems and pitfalls in cardiac drug therapy.

作者信息

Stone S M, Rai N, Nei J

机构信息

Department of Pharmacy Services, Cedars-Sinai Medical Center, Los Angeles, CA, USA.

出版信息

Rev Cardiovasc Med. 2001 Summer;2(3):126-42.

PMID:12439377
Abstract

Medical errors in the care of patients may account for 44,000 to 98,000 deaths per year, and 7,000 deaths per year are attributed to medication errors alone. Increasing awareness among health care providers of potential errors is a critical step toward improving the safety of medical care. Because today's medications are increasingly complex, approved at an accelerated rate, and often have a narrow therapeutic window with only a small margin of safety, patient and provider education is critical in assuring optimal therapeutic outcomes. Providers can use electronic resources such as Web sites to keep informed on drug-drug, drug-food, and drug-nutritional supplements interactions.

摘要

相似文献

1
Problems and pitfalls in cardiac drug therapy.
Rev Cardiovasc Med. 2001 Summer;2(3):126-42.
2
[Drug therapy in advanced age].[老年患者的药物治疗]
Med Monatsschr Pharm. 1996 May;19(5):132-9.
3
Baseline laboratory monitoring of cardiovascular medications in elderly health maintenance organization enrollees.老年健康维护组织参保者心血管药物的基线实验室监测
J Am Geriatr Soc. 2005 Dec;53(12):2165-9. doi: 10.1111/j.1532-5415.2005.00498.x.
4
Adverse drug reactions in patients with cardiovascular disease.心血管疾病患者的药物不良反应。
Curr Probl Cardiol. 2008 Dec;33(12):703-68. doi: 10.1016/j.cpcardiol.2008.08.002. Epub 2008 Sep 27.
5
[Interactions of cardiac and antiretroviral medication].[心脏药物与抗逆转录病毒药物的相互作用]
Herz. 2005 Sep;30(6):493-503. doi: 10.1007/s00059-005-2723-4.
6
Sexual dysfunction and cardiac risk (the Second Princeton Consensus Conference).性功能障碍与心脏风险(第二届普林斯顿共识会议)
Am J Cardiol. 2005 Jul 15;96(2):313-21. doi: 10.1016/j.amjcard.2005.03.065.
7
Cardiovascular medications in primary care: treatment gaps and targeting by absolute risk.基层医疗中的心血管药物:治疗差距与绝对风险靶向治疗
N Z Med J. 2005 Oct 7;118(1223):U1676.
8
Medication errors: an analysis comparing PHICO's closed claims data and PHICO's Event Reporting Trending System (PERTS).用药差错:一项比较PHICO的结案索赔数据与PHICO事件报告趋势系统(PERTS)的分析。
J Clin Pharmacol. 2003 Jul;43(7):754-9.
9
[An analysis of pharmacotherapy in an internal medicine ambulatory care clinic, using the example of cardiovascular-effective drugs].[以内科门诊心血管有效药物为例的药物治疗分析]
Schweiz Med Wochenschr. 1981 Aug 4;111(31-32):1163-8.
10
Polypharmacy in older oncology patients and the need for an interdisciplinary approach to side-effect management.老年肿瘤患者的多重用药情况以及采用跨学科方法管理副作用的必要性。
J Clin Pharm Ther. 2007 Apr;32(2):169-75. doi: 10.1111/j.1365-2710.2007.00815.x.

引用本文的文献

1
Using Physiologically Based Pharmacokinetic Models for Assessing Pharmacokinetic Drug-Drug Interactions in Patients with Chronic Heart Failure Taking Narrow Therapeutic Window Drugs.使用基于生理的药代动力学模型评估服用窄治疗窗药物的慢性心力衰竭患者的药代动力学药物-药物相互作用。
Pharmaceuticals (Basel). 2025 Mar 27;18(4):477. doi: 10.3390/ph18040477.